Copyright: ©Author(s) 2026.
World J Hepatol. Oct 27, 2026; 18(10): 124666
Published online Oct 27, 2026. doi: 10.4254/wjh.124666
Published online Oct 27, 2026. doi: 10.4254/wjh.124666
Figure 4 Distribution of pathobionts in the microbiota and mycobiota of patients with clinically significant portal hypertension.
A: Distribution of pathobionts in the microbiota of cirrhotic patients with clinically significant portal hypertension (CSPH); B: Distribution of pathobionts in the mycobiota of cirrhotic patients with CSPH; C: Distribution of pathobionts in both the microbiota and mycobiota of cirrhotic patients with CSPH.
- Citation: Colucci G, Stella S, Castagnetti A, Di Rito L, Lucà M, Tosetti G, D’Ambrosio R, Lampertico P. Gut microbiome in patients with cirrhosis and clinically significant portal hypertension: A pilot study. World J Hepatol 2026; 18(10): 124666
- URL: https://www.wjgnet.com/1948-5182/full/v18/i10/124666.htm
- DOI: https://dx.doi.org/10.4254/wjh.124666